Large molecule bioanalysis by LC–MS: beyond simply quantifying

References

• 1. van de Merbel NC, Bronsema KJ, Nemansky M. Protein quantification using LC–MS: can it make a difference? Bioanalysis 4(17), 2113–2116 (2012).
  Google Scholar
• 2. Bronsema KJ, Bischoff R, van de Merbel NC. High-sensitivity LC–MS/MS quantification of peptides and proteins in complex biological samples: the impact of enzymatic digestion and internal standard selection on method performance. Anal. Chem. 85(20), 9528–9535 (2013).
  Medline CASGoogle Scholar
• 3. Bischoff R, Bronsema KJ, van de Merbel NC. Analysis of biopharmaceutical proteins in biological matrices by LC–MS/MS – I. Sample preparation. Trends Anal. Chem. 48, 41–51 (2013).
  CASGoogle Scholar
• 4. Wilffert D, Reis CR, Hermans J et al. Antibody-free LC–MS/MS analysis of recombinant tumor necrosis factor-related apoptosis inducing ligand (TRAIL) in human and mouse serum. Anal. Chem. 85(22), 10754–10760 (2013).
  Medline CASGoogle Scholar
• 5. Bronsema KJ, Bischoff R, Bouche MP, Mortier K, van de Merbel NC. High-sensitivity quantification of a nanobody in plasma by single-cartridge multi-dimensional SPE and ultra-performance LC–MS/MS. Bioanalysis 7(1), 53–64 (2015).
  CASGoogle Scholar
• 6. Wilffert D, Bischoff R, van de Merbel NC. Antibody-free workflows for protein quantification by LC– MS. Bioanalysis 7(6), 763–779 (2015).
  CASGoogle Scholar
• 7. Wilffert D, Donzelli R, Asselman A et al. Quantitative antibody-free LC–MS/MS analysis of sTRAIL in sputum and saliva at the sub-ng/ml level. J. Chromatogr. B. 1032, 205–210 (2016).
  Medline CASGoogle Scholar
• 8. Klont F, Pouwels SD, Hermans J et al. A fully validated liquid chromatography-mass spectrometry method for the quantification of the soluble receptor of advanced glycation end-products (sRAGE) in serum using immunopurification in a 96-well plate format. Talanta 182, 414–421 (2018).
  Medline CASGoogle Scholar
• 9. Klont F, Pouwels SD, Bults P et al. Quantification of surfactant protein D (SPD) in human serum by liquid chromatography-mass spectrometry (LC–MS). Talanta 202, 507–513 (2019).
  Medline CASGoogle Scholar
• 10. Bronsema KJ, Bischoff R, Pijnappel WWMP, van der Ploeg AT, van de Merbel NC. Absolute quantification of the total and antidrug antibody-bound concentrations of recombinant human α-glucosidase in human plasma using protein G extraction and LC–MS/MS. Anal. Chem. 87(8), 4394–4401 (2015).
  Medline CASGoogle Scholar
• 11. van de Merbel NC. Protein quantification by LC–MS: a decade of progress through the pages of Bioanalysis. Bioanalysis 11(7), 629–644 (2019).
  Google Scholar
• 12. Bults P, van de Merbel NC, Bischoff R. Quantification of biopharmaceuticals and biomarkers in complex biological matrices: a comparison of liquid chromatography coupled to tandem mass spectrometry and ligand binding assays. Expert Rev. Proteomics 12, 355–374 (2015).
  Medline CASGoogle Scholar
• 13. Bults P, Bischoff R, Bakker H, Gietema JA, van de Merbel NC. LC–MS/MS based monitoring of in vivo protein biotransformation: quantitative determination of trastuzumab and its deamidation products in human plasma. Anal. Chem. 88(2), 1871–1877 (2016).
  Medline CASGoogle Scholar
• 14. Bults P, Meints M, Sonesson A, Knutsson M, Bischoff R, van de Merbel NC. Improving selectivity and sensitivity of protein quantitation by LC-HR-MS/MS: determination of somatropin in rat plasma. Bioanalysis 10(13), 1009–1021 (2018).
  CASGoogle Scholar
• 15. Bults P, van der Voort A, Meijer C, Sonke GS, Bischoff R, van de Merbel NC. Analytical and pharmacological consequences of the in vivo deamidation of trastuzumab and pertuzumab. Anal. Bioanal. Chem. 414, 1513–1524 (2022).
  Medline CASGoogle Scholar
• 16. Olaleye O, Govorukhina N, van de Merbel NC, Bischoff R. Non-antibody-based binders for the enrichment of proteins for analysis by mass spectrometry. Biomolecules. accepted for publication.
  Google Scholar
• 17. Olaleye O, Spanov B, Ford R, Govorukhina N, van de Merbel NC, Bischoff R. Enrichment and liquid chromatography-mass spectrometry analysis of trastuzumab and pertuzumab using Affimer^® reagents. Anal. Chem. 93(40), 13597–13605 (2021).
  Medline CASGoogle Scholar
• 18. Bults P, Spanov B, Olaleye O, van de Merbel NC, Bischoff R. Intact protein bioanalysis by liquid chromatography – high-resolution mass spectrometry. J. Chromatogr. B. 1110-1111, 155–167 (2019).
  Medline CASGoogle Scholar
• 19. Spanov B, Aboagye V, Olaleye O, Govorukhina N, van de Merbel NC, Bischoff R. Effect of trastuzumab-HER2 complex formation on stress-induced modifications in the CDRs of trastuzumab. Front. Chem. 9, 794247 (2022).
  MedlineGoogle Scholar
• 20. Spanov B, Govorukhina N, van de Merbel NC, Bischoff R. Analytical tools for the characterization of deamidation in monoclonal antibodies. J. Chromatogr. Open 2, 100025 (2022).
  Google Scholar
• 21. Spanov R, Olaleye O, Lingg N et al. Change of charge variant composition of trastuzumab upon stressing at physiological conditions. J. Chromatogr. A. 1655, 462506 (2021).
  Medline CASGoogle Scholar
• 22. Bults P, Sonesson A, Knutsson M, Bischoff R, van de Merbel NC. Intact protein quantification in biological samples by liquid chromatography – high-resolution mass spectrometry: somatropin in rat plasma. J. Chromatogr. B. 1144, 122079 (2020).
  Medline CASGoogle Scholar